4-Pentynoyl-Val-Ala-PAB-Cl

Nom chimique: 4-Penynoyl-valyl-alanyl-(4-aminobenzyl chloride) // Synonymes: N-((S)-1-(((S)-1-((4-(chloromethyl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)pent-4-ynamide, 4-Pentynoyl-VA-PAB-Cl

  • n° Art.:ADC1690
  • Formule:C20H26ClN3O3
  • Masse moléculaire:391,90 g/mol

Starting at 450,00 €

Grouped product items
Nombre Unité de vente Prix SKU
100 mg
450,00 €
ADC1690.0100
250 mg
900,00 €
ADC1690.0250
description

Linker for Antibody-Drug-Conjugation (ADC). In contrast to the hydroxybenzyl derivative ADC1310 the chloride is able to react with tertiary amines to form a linked quarternary amine. The Val-Ala will specifically be cleaved by Cathepsin B. As this enzyme is only present in the lysosome the ADC payload will be released only in the cell. The alkyne moiety allows versatile conjugation e.g. via Click Chemistry.


references

Laurent Ducry (ed.), Antibody-Drug Conjugates, Methods in Molecular Biology, vol. 1045, Springer Science+Business Media, LLC 2013; https://doi.org/10.1007/978-1-62703-541-5_5.


NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity; R. J. Anderson, B. J. Compton, C.-W. Tang, A. Authier-Hall, C. M. Hayman, G. W. Swinerd, R. Kowalczyk, P. Harris, M. A. Brimble, D. S. Larsen, O. Gasser, R. Weinkove, I. F. Hermans, G. F. Painter; Chem. Sci. 2015; 6: 5120-5127. https://doi.org/10.1039/C4SC03599B.


Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates; P. J. Burke, J. Z. Hamilton, T. A. Pires, J. R. Setter. J. H. Hunter, J. H. Cochran, A. B. Waight, K. A. Gordon, B. E. Toki, K. K. Emmerton, W. Zeng, I. J. Stone, P. D. Senter, R. P. Lyon, S. C. Jeffrey; Mol. Cancer Ther. 2016; 15(5): 938-954. https://doi.org/10.1158/1535-7163.MCT-16-0038.

Commande groupée?

Vous avez besoin de plus grandes quantités pour votre développement ou production?

Besoin d'informations supplémentaires sur ce produit?

entrer en contact

Contact rapide

Veuillez m'envoyer plus d'informations sur

Des produits qui pourraient également vous intéresser!